You are here

Heart Failure

 - SPECT/CT, LVAD. molecular imaging, structural heart

Nearly one-third of patients had cognitive decline one year after undergoing left ventricular assist device (LVAD) implantation for advanced heart failure, according to an analysis of a large, multicenter, observational registry

 - Heart Failure - Don't use until 3/1/12

Patients with acute heart failure had an increased risk of all-cause mortality after being discharged from the hospital if they had a low level of health literacy, according to a retrospective study. After adjusting for various factors, the risk of death for patients with low health literacy was 32 percent higher than for patients with higher health literacy.

 - ecg, heart, electrophysiology

People with Hodgkin lymphoma have a high risk for various cardiovascular diseases for decades after their initial diagnosis, according to a retrospective cohort study.

 - heart, cardiology, cardiac

The incidence of heart failure dropped steeply over a decade in a population-based study, and while hospitalization rates remained steady over time, causes shifted from cardiovascular to noncardiovascular.

 - pills

The FDA approved ivabradine to reduce the risk of hospitalization in patients with heart failure. The agency had expedited its evaluation of the drug under its priority review program.


More Stories

Caregivers of destination LVAD patients benefit from support, too

Patients aren’t the only ones impacted by destination therapy left ventricle assist device (LVAD) implants. Caregivers should be part of decision-making and they need support and tools to help them process the change, according to a study.

Sunshine Heart suspends trial after reports of deaths

Sunshine Heart put its U.S. pivotal clinical trial on hold after receiving reports of four deaths among the study’s participants.

HeartWare recall targets clinical trial participants

HeartWare International issued a voluntary recall in the U.S. of older controllers that were distributed during clinical trials.

Donor heart acceptance rate drops as demand rises

Despite growing waiting lists and national efforts to increase the use of available donor organs, the rate of hearts accepted for transplantation has decreased significantly since 1995, a study found.

Cardiologist-driven heart failure care may improve short-term outcomes

Patients with acute decompensated heart failure may benefit more from care by a cardiologist than a non-cardiologist, according to a study published in the February issue of the American Journal of Cardiology.

Review of hospital care finds high rates of IV fluids given for acute heart failure

Early care with intravenous (IV) fluid is not recommended by guidelines for patients with acute decompensated heart failure. However, 11 percent of patients in a study published Feb. 1 in the Journal of the American College of Cardiology: Heart Failure received IV fluid and diuretics in the first two days of hospitalization. 

Pigskins & not porking out

Heart failure is one of the most expensive diseases in the U.S., with many boomerang patients and a stinging financial penalty from Medicare for hospitals with higher than expected 30-day readmissions. It doesn’t need to be that way.

Listen up: Heart failure tool helps ID barriers to self-care

Putting a stop to boomerang heart failure readmissions may require a sympathetic ear in the emergency department (ED). One pilot test has shown that it is possible to identify patients’ barriers to self-care, even in a busy ED setting.

FDA gives pump to support right heart its blessing

The FDA granted Abiomed a Humanitarian Device Exemption for a percutaneous single-access heart pump for patients who develop right heart failure or decompensation.

Super Bowl super bad for intemperate fans with heart failure

Call it Monday morning quarterbacking, but with the chance to actually change the game. Based on one study, hospitals likely will see in uptick in heart failure admissions after Super Bowl Sunday—but cardiologists still have time to coach their patients to play it smart.

LVAD, healer of broken hearts? Heart failure biomarkers suggest yes

A look into cardiomyocytes and DNA damage response may offer new hope for patients with heart failure. Long-term use of left ventricular assist devices (LVADs) may encourage the heart to repair itself at a cellular level.

Something to toast: Moderate drinking may reduce risk for heart failure

A little nip may not hurt the heart. Secondary analysis of Atherosclerosis Risk in Communities data found moderate drinkers had lower risk for cardiovascular events than those who had more to drink or abstained. Findings were similar for both men and women.

Salt shakes its bad rap for upping risk of death, heart diseases

Take it with a grain of salt: In older adults, self-reported sodium intake was not associated with risk for cardiovascular disease, heart failure and mortality, according to a study published online Jan. 19 in JAMA Internal Medicine.

Heart failure discharge summaries miss mark

With Medicare penalties now at 3 percent for 30-day heart failure readmissions, many hospitals are eager to find opportunities to improve outcomes. Based on a study published online Jan. 13, discharge summaries might fit the bill.

Quality of life for heart failure patients may start with accepting illness

The ability to function with heart failure and a patient’s acceptance of his or her condition may go hand in hand. A Polish study used illness acceptance screening to reveal patterns in patient responses to quality of life surveys.

Heart failure blood sugar levels at ED intake predict risks for death, hospitalization

Patients who arrived at the emergency department with acute heart failure syndromes and mildly elevated blood glucose levels may be at increased risk for death or hospitalization within the first 30 days, according to a study published online Jan. 7 in the European Heart Journal.

Heart failure combo drug keeps deterioration at bay

PARADIGM-HF already underscored the mortality benefit of a new combo drug for patients with chronic heart failure. Now a study that looked into clinical outcomes gave it high scores for halting the progression of heart failure in survivors.

Obese heart failure patients outlive leaner cohorts in population study

Continuing the debate over the so-called “obesity paradox,” more obese and overweight patients may develop heart failure, but fewer die from it than lean counterparts, according to a study published in the Dec. 30 issue of the Journal of the American College of Cardiology.

FDA clears way for two quadripolar leads

The FDA approved two quadripolar leads for use in cardiac resynchronization therapy defibrillators for patients with heart failure.

Scorpion’s sting may hold clue for managing heart failure

It was only a pilot study, and only in mice, and it requires harvesting venom from scorpions—no easy task. But a first report on a venom-based peptide points to a new compound for treating patients with acute heart failure.